| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| EyePoint Pharmaceuticals, Inc. | Director | Stock Options (Right to buy) | 80,000 | 08 Jan 2025 | Direct | ||
| EyePoint, Inc. | Director | Stock Option (Right to Buy) | 40,000 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EYPT | EyePoint, Inc. | 02 Jan 2026 | 1 | $0 | 4 | Director | 06 Jan 2026, 16:08 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 08 Jan 2025 | 1 | $0 | 4 | Director | 08 Jan 2025, 16:14 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 08 Jan 2025 | 0 | $0 | 3 | Director | 08 Jan 2025, 16:11 |